SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-021662
Filing Date
2023-08-02
Accepted
2023-08-02 16:18:44
Documents
15
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230802_8k.htm   iXBRL 8-K 33380
2 EXHIBIT 99.1 ex_553743.htm EX-99.1 13820
7 pic1.jpg GRAPHIC 3324
  Complete submission text file 0001437749-23-021662.txt   193714

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20230802.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230802_def.xml EX-101.DEF 11806
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230802_lab.xml EX-101.LAB 15857
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230802_pre.xml EX-101.PRE 12021
9 EXTRACTED XBRL INSTANCE DOCUMENT arav20230802_8k_htm.xml XML 2653
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 231135900
SIC: 2834 Pharmaceutical Preparations